Suggestions
Ghermes Chilov
CEO at Fusion Pharma, 32 Cure, Ibraco
Ghermes Chilov is an accomplished professional with a strong academic background.
He studied at Lomonosov Moscow State University (MSU), showcasing a dedication to education and learning.
With an impressive career trajectory, Ghermes Chilov has held key executive positions in various organizations.
Currently serving as the Chief Executive Officer at Ibraco, LLC, he brings leadership and strategic vision to the company.
Prior to this role, Ghermes Chilov served as the Chief Executive Officer at 32 Cure, LLC, demonstrating his ability to drive success in different business environments.
His experience also includes being the General Director at Fusion Pharma, where he led the company with expertise and innovation.
Additionally, Ghermes Chilov held the position of General Director at Molecular Technologies, LLC, further showcasing his diverse skills and knowledge in the industry.
His professional journey started as a Doctor at Lomonosov Moscow State University, where he laid the foundation for his successful career.
Ghermes Chilov's rich and varied experience makes him a valuable asset in the field, bringing a wealth of expertise and insights to any organization he is a part of.
